Medroxyprogesterone Acetate Patent Expiration

Medroxyprogesterone Acetate was first introduced by Pfizer Inc in its drug Provera on Approved Prior to Jan 1, 1982. Other drugs containing Medroxyprogesterone Acetate are Depo-Subq Provera 104, Depo-Provera. 17 different companies have introduced drugs containing Medroxyprogesterone Acetate.


Medroxyprogesterone Acetate Patents

Given below is the list of patents protecting Medroxyprogesterone Acetate, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Depo-subq Provera 104 US6495534 Stabilized aqueous suspensions for parenteral use May 15, 2020

(Expired)

Pfizer



Medroxyprogesterone Acetate Generics

Several generic applications have been filed for Medroxyprogesterone Acetate. The first generic version for Medroxyprogesterone Acetate was by Solvay Pharmaceuticals and was approved on Approved Prior to Jan 1, 1982. And the latest generic version is by Amneal Eu Ltd and was approved on Jun 7, 2023.

Given below is the list of companies who have filed for Medroxyprogesterone Acetate generic.


1. AMARIN PHARMS

Amarin Pharmaceuticals Inc has filed for 1 generic for Medroxyprogesterone Acetate. This 10mg version comes by the name AMEN. Given below are the details of the strengths of this generic introduced by Amarin Pharms.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982


2. AMNEAL

Amneal Eu Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Amneal.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Prescription INJECTION AB Jun 7, 2023


3. AMPHASTAR PHARMS INC

Amphastar Pharmaceuticals Inc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Amphastar Pharms Inc.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Prescription INJECTION AB Nov 28, 2017


4. BARR

Barr Laboratories Inc has filed for 3 different strengths of generic version for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
2.5MG tablet Prescription ORAL AB Aug 9, 1996
10MG tablet Prescription ORAL AB Aug 9, 1996
5MG tablet Prescription ORAL AB Aug 9, 1996


5. CIPLA

Cipla Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Cipla.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Discontinued INJECTION N/A Jan 25, 2019


6. DURAMED PHARMS BARR

Duramed Pharmaceuticals Inc Sub Barr Laboratories Inc has filed for 3 different strengths of generic version for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Duramed Pharms Barr.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Dec 1, 1999
5MG tablet Discontinued ORAL N/A Dec 1, 1999
2.5MG tablet Discontinued ORAL N/A Dec 1, 1999


7. ESI

Esi Pharmacal has filed for 3 different strengths of generic version for Medroxyprogesterone Acetate. All of these versions come by the name CYCRIN. Given below are the details of the strengths of this generic introduced by Esi.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Sep 9, 1987
5MG tablet Discontinued ORAL N/A Oct 30, 1992
2.5MG tablet Discontinued ORAL N/A Oct 30, 1992


8. EUGIA PHARMA

Eugia Pharma Specialities Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Eugia Pharma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Prescription INJECTION AB Aug 31, 2022


9. HIKMA

Hikma Pharmaceuticals Usa Inc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Hikma.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Discontinued INJECTION N/A Jan 5, 2023


10. HONG KONG

Hong Kong King Friend Industrial Co Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Hong Kong.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Prescription INJECTION AB Jul 28, 2004


11. SANDOZ

Sandoz Inc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Sandoz.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Discontinued INJECTION N/A May 20, 2009


12. SOLVAY

Solvay Pharmaceuticals has filed for 1 generic for Medroxyprogesterone Acetate. This 10mg version comes by the name CURRETAB. Given below are the details of the strengths of this generic introduced by Solvay.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Approved Prior to Jan 1, 1982


13. SUN PHARM

Sun Pharmaceutical Industries Ltd has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Sun Pharm.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Discontinued INJECTION N/A May 1, 2019


14. TEVA PHARMS USA

Teva Pharmaceuticals Usa has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Discontinued INJECTION N/A Oct 27, 2004


15. UPSHER SMITH LABS

Upsher Smith Laboratories Llc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Upsher Smith Labs.

Strength Dosage Form Availability Application Pathway TE code Launch Date
10MG tablet Discontinued ORAL N/A Jul 26, 1984


16. XIROMED

Xiromed Llc has filed for 1 generic for Medroxyprogesterone Acetate. Given below are the details of the strengths of this generic introduced by Xiromed.

Strength Dosage Form Availability Application Pathway TE code Launch Date
150MG/ML injectable Prescription INJECTION AB Oct 12, 2018